Illumina (ILMN) Cash & Equivalents (2009 - 2026)

Illumina (ILMN) has reported Cash & Equivalents for 18 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $1.1 billion, down 2.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 2.16% YoY), and the FY2025 annual result was $1.4 billion, up 25.82% from the prior year.
• Cash & Equivalents was $1.1 billion for Q1 2026 at Illumina, down from $1.4 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $2.0 billion in Q1 2023 and troughed at $869.0 million in Q3 2024.
• Average Cash & Equivalents over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2024.
• Year-over-year, Cash & Equivalents tumbled 69.52% in 2022 and jumped 63.23% in 2023.
• Over 5 years, Cash & Equivalents stood at $1.0 billion in 2022, then rose by 4.8% to $1.0 billion in 2023, then gained by 7.54% to $1.1 billion in 2024, then increased by 25.82% to $1.4 billion in 2025, then slipped by 23.2% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $1.1 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.0 billion in Q3 2025.